Senores Pharmaceuticals Limited (NSE:SENORES)
India · Delayed Price · Currency is INR 1,173.70
-1.30 (-0.11%)
Nov 11, 2026, 1:55 PM IST
Senores Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Senores Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of ₹1,572. The average 1-year stock price forecast is 33.90% higher than the current stock price, while the lowest is ₹1,500 (+27.80%) and the highest is ₹1,700 (+44.84%).
Price Target: ₹1,572 (+33.90%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Senores Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 3 | 4 |
| Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 5 |
Financial Forecast
Revenue This Year
8.80B
from 6.33B
Increased by 39.13%
Revenue Next Year
11.69B
from 8.80B
Increased by 32.81%
EPS This Year
33.84
from 26.39
Increased by 28.23%
EPS Next Year
46.66
from 33.84
Increased by 37.88%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.